Madrigal Pharmaceuticals had a revenue of 311.34M in the quarter ending Mar 31, 2026, with -3.04%. This bring the company's revenue in the last twelve months to 1.13B, Decreased 18.16%. In the fiscal year ending Dec 31, 2025, Madrigal Pharmaceuticals had annual revenue of 958.40M with 432.05% growth.